Exploratory Evaluation of Bezlotoxumab on Outcomes Associated With Clostridioides difficile Infection in MODIFY I/II Participants With Cancer

BACKGROUND: The incidence of Clostridioides difficile infection (CDI) is reportedly higher and the cure rate lower in individuals with cancer vs those without cancer. An exploratory post hoc analysis of the MODIFY I/II trials (NCT01241552/NCT01513239) investigated how bezlotoxumab affected the rate...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Open Forum Infect Dis
Hlavní autoři: Cornely, Oliver A, Mullane, Kathleen M, Birch, Thomas, Hazan-Steinberg, Sabine, Nathan, Richard, Bouza, Emilio, Calfee, David P, Ellison, Misoo Chung, Wong, Michael T, Dorr, Mary Beth
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2020
Témata:
Major Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7029680/
https://ncbi.nlm.nih.gov/pubmed/32099847
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofaa038
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky